HALO Growth 100 · Sector S2
Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | Natera | NAM | 341.79 | +3.91% | +4.15% | +9.98% | +61.17% | +81.95% | +96.65% | USD |
| ILMN | Illumina | NAM | 208.21 | +0.85% | -4.59% | +8.08% | +29.35% | +75.05% | +109.66% | USD |
| GXI.DE | Gerresheimer | EUR | 27.50 | -2.55% | -7.84% | +1.25% | +7.09% | +42.19% | -36.19% | EUR |
| VRTX | Vertex Pharma | NAM | 519.51 | +0.79% | -4.87% | +0.59% | +16.76% | +10.69% | +30.74% | USD |
| REGN | Regeneron | NAM | 793.74 | +1.57% | -4.11% | -1.52% | +29.67% | +6.43% | +40.04% | USD |
| VKTX | Viking Therapeutics | NAM | 31.53 | -1.41% | -9.58% | -4.28% | +9.67% | -11.51% | +22.49% | USD |
| LLY | Eli Lilly | NAM | 1138.28 | +2.02% | -0.96% | -5.85% | +0.47% | +15.55% | +50.98% | USD |
| NVO | Novo Nordisk | EUR | 43.45 | +0.88% | -6.76% | -7.00% | -0.98% | +18.66% | -17.05% | USD |
| AMGN | Amgen | NAM | 381.50 | +1.10% | -12.75% | -8.70% | +7.40% | +4.18% | +36.84% | USD |
| ZEAL.CO | Zealand Pharma | EUR | 278.70 | +0.18% | -8.53% | -13.23% | -1.17% | +3.22% | -34.88% | DKK |